You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-23, IL-23, guselkumab, Tremfya

Showing 1 - 25 of 5,273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

Recruiting
  • Psoriasis
  • Psoriasis Vulgaris
  • Brussels, Belgium
  • +18 more
Dec 5, 2022

Alcoholic Liver Disease Trial in La Jolla (Guselkumab 30mg, Guselkumab 70mg, Guselkumab 100mg)

Recruiting
  • Alcoholic Liver Disease
  • Guselkumab 30mg
  • +2 more
  • La Jolla, California
    University of California, San Diego
May 3, 2021

Guselkumab and Interleukin-17 Inhibitor Therapies in Psoriatic

Recruiting
  • Arthritis, Psoriatic
  • Buenos Aires, Argentina
  • +149 more
Aug 11, 2022

Pityriasis Rubra Pilaris Trial in Portland (guselkumab)

Active, not recruiting
  • Pityriasis Rubra Pilaris
  • guselkumab
  • Portland, Oregon
    Oregon Health and Science University
Apr 8, 2022

Arthritis, Juvenile Trial in Worldwide (Ustekinumab, Guselkumab)

Recruiting
  • Arthritis, Juvenile
  • Birmingham, Alabama
  • +50 more
Jan 31, 2023

Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)

Not yet recruiting
  • Psoriatic Arthritis
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 18, 2022

Adenomatous Polyposis Coli Trial in Worldwide (Guselkumab, Placebo)

Completed
  • Adenomatous Polyposis Coli
  • Phoenix, Arizona
  • +31 more
Jul 14, 2022

Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)

Not yet recruiting
  • Psoriatic Arthritis
  • Philadelphia, Pennsylvania
    Hospital at the University of Pennsylvania
Dec 20, 2022

Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Golimumab, Placebo)

Recruiting
  • Arthritis, Psoriatic
  • Phoenix, Arizona
  • +96 more
Jan 17, 2023

IL-23-Responsive Immune Cell Subsets in Post-Operative

Recruiting
  • Crohn´s Disease
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam UMC
    Aug 16, 2023

    Giant Cell Arteritis Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Giant Cell Arteritis
    • Kansas City, Kansas
    • +33 more
    Aug 11, 2022

    Crohn's Disease Trial in Worldwide (Guselkumab, Placebo)

    Not yet recruiting
    • Crohn's Disease
    • Phoenix, Arizona
    • +82 more
    Jun 20, 2023

    Hidradenitis Suppurativa Trial in New York (Guselkumab)

    Withdrawn
    • Hidradenitis Suppurativa
    • New York, New York
      Rockefeller Unviersity
    Jun 3, 2020

    Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Arthritis, Psoriatic
    • Chandler, Arizona
    • +263 more
    Jan 17, 2023

    Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

    Completed
    • Metastatic Pancreatic Adenocarcinoma
    • +3 more
    • Aldesleukin
    • +9 more
    • Detroit, Michigan
      Wayne State University/Karmanos Cancer Institute
    Mar 30, 2022

    Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)

    Recruiting
    • Arthritis, Psoriatic
    • Mountain Brook, Alabama
    • +199 more
    Jan 17, 2023

    Psoriasis of Scalp Trial in San Francisco (Guselkumab)

    Recruiting
    • Psoriasis of Scalp
    • San Francisco, California
      University of California San Francisco
    May 4, 2023

    Periodontitis, Gingivitis, Periodontal Health Trial in Aydin (Periodontal clinical measurements, GCF and saliva sampling)

    Completed
    • Periodontitis
    • +2 more
    • Periodontal clinical measurements, GCF and saliva sampling
    • Aydın, Turkey
      Aydın Adnan Menderes University
    Oct 26, 2023

    Tildrakizumab in Difficult-to-treat Areas in Psoriasis

    Recruiting
    • Psoriasis Palmaris
    • +4 more
    • Psoriasis clinical assessments
    • +3 more
    • Paris, France
      Service de Dermatologie- Hopital Saint Joseph
    Jul 3, 2023

    Crohn Disease Trial in Calgary (TNFa Antagonist - Infliximab, TNFa Antagonist - Adalimumab, Anti-IL12/23 or anti-IL23 -

    Not yet recruiting
    • Crohn Disease
    • TNFa Antagonist - Infliximab
    • +5 more
    • Calgary, Alberta, Canada
      University of Calgary
    Jun 22, 2023

    Psoriasis Trial in Worldwide (Guselkumab)

    Recruiting
    • Psoriasis
    • Frankfurt, Germany
    • +7 more
    Jan 17, 2023

    Psoriasis Guttate, Plaque Psoriasis Trial in San Francisco (Guselkumab)

    Recruiting
    • Psoriasis Guttate
    • Plaque Psoriasis
    • San Francisco, California
      UCSF Psoriasis and Skin Treatment Center
    Apr 28, 2022

    Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis Trial in Worldwide (Brodalumab, Placebo, Guselkumab)

    Completed
    • Plaque Psoriasis
    • +2 more
    • Brodalumab
    • +2 more
    • Wien, Austria
    • +52 more
    Jan 11, 2023

    Chronic Plaque-type Psoriasis Trial in Canada, Germany, United States (Skin biopsies)

    Completed
    Has Results
    • Chronic Plaque-type Psoriasis
    • Skin biopsies
    • New Orleans, Louisiana
    • +13 more
    Oct 7, 2021

    Psoriasis Trial in Canada, United States (Guselkumab, Placebo)

    Recruiting
    • Psoriasis
    • Boston, Massachusetts
    • +4 more
    Sep 29, 2022